early rhythm control - search results
If you're not happy with the results, please do another search
Health benefits of early rhythm control come with “reasonable” costs for patients with atrial...
Patients with atrial fibrillation (AF) have been said to benefit from early rhythm control therapy, which reduces cardiovascular deaths, strokes, and other adverse outcomes...
Early rhythm control aids recurrent stroke prevention in patients with AF
Early rhythm control one year after atrial fibrillation (AF) diagnosis has been found to be beneficial in preventing recurrent stroke in patients with incident...
Recent AF diagnosis and multiple comorbidities warrants early rhythm control strategy
Patients with recently diagnosed atrial fibrillation (AF) with a high burden of comorbidities should be considered for early rhythm control to reduce cardiovascular outcomes,...
“Solid” data point to benefit of early rhythm control for AF patients
Findings of the EAST-AFNET 4 trial, examining the benefit of early rhythm control therapy in patients with newly diagnosed atrial fibrillation (AF), should influence...
HRS 2021: Early rhythm control benefits AF patients with heart failure
Rhythm control therapy offers a clinical benefit when initiated within one year of a diagnosis of atrial fibrillation (AF) in patients with signs or...
ESC Congress 2020: EAST-AFNET 4 finds early rhythm control improves AF outcomes
Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot...
One thousand arrhythmia patients treated using Stereotaxis robotic system
Stereotaxis has announced that over 1,000 cardiac arrhythmia patients have been treated using the Genesis Robotic Magnetic Navigation (RMN) system.
Genesis RMN, was first used...
“First study” finds six-fold increase in bradyarrhythmia diagnosis using long-term ILR screening
A retrospective analysis of randomised clinical trials has found that one in five patients aged 70 years or older with cardiovascular risk factors are...
HRS 2021: Early VT catheter ablation beats medical therapy in patients at risk for...
Results of the PAUSE-SCD trial show a significant reduction in risk of ventricular tachycardia (VT) recurrence, cardiovascular hospitalisation, and death when catheter ablation is...
AF Symposium 2021: Experts debate early ablation strategy in AF
The merits of catheter ablation as a first-line treatment for atrial fibrillation (AF) were considered during the second day of AF Symposium 2021 (29–31...
Fitness linked to lower arrhythmia recurrence after AF ablation
Patients undergoing atrial fibrillation (AF) ablation, who are physically fit before the procedure, have a much higher chance of benefiting from the procedure and...
Tenfold risk of arrhythmias in intensive care COVID-19 patients
Patients with COVID-19 who were admitted to an intensive care unit were 10 times more likely than other hospitalised COVID-19 patients to suffer cardiac...
Focus on the Zio Patch wearable sensor in diagnosis of cardiac arrhythmias
James Teo was the chief investigator in the EPACS clinical trial, testing the performance of the Zio Patch (iRhythm Technologies) wearable biosensor. He outlines...
EHRA 2020 to feature late-breaking arrhythmia studies
Twenty late-breaking trials, including major clinical studies on the treatment of atrial fibrillation (AF) are among the research to be presented at the annual...
iRhythm and Verily to collaborate on health management solutions for atrial fibrillation patients
iRhythm Technologies has announced a collaboration with Verily to develop solutions aimed at improving the screening, diagnosis, and management of patients with atrial fibrillation...
Mapping early sites of activation for AF can be used to guide ablation
A stochastic vector-based approach to mapping and ablation of atrial fibrillation (AF) can be used to determine early sites of activation and to guide...
Atrial fibrillation related to PFO closure occurs early and is transient
A new meta-analysis of patients undergoing percutaneous closure of patent foramen ovale (PFO) after cryptogenic shock supports previous studies that indicate PFO closure is...
Autonomic modulation for refractory ventricular arrhythmias: Going beyond the heart
Patients with scar-related ventricular tachycardia (VT) do not often achieve a cure. Jason S Bradfield and Kalyanam Shivkumar write in Cardiac Rhythm News about...
Tenth edition of EHRA White Book of cardiac arrhythmia treatment data released
The tenth year of data on cardiac arrhythmia treatment is being launched at EHRA EUROPACE - CARDIOSTIM 2017.
The edition marks the ten year anniversary...
King’s College London joins with Cambridge Design Partnership to further develop a new steerable...
Cambridge Design Partnership recently announced it is working with Kings College London to further develop a new steerable catheter designed to treat complex cardiac...
Is antiarrhythmic gene therapy the future of atrial fibrillation management?
Dierk Thomas (Heidelberg, Germany) writes on the results of preclinical research on antiarrhythmic gene therapy.
Advanced Cardiac Therapeutics announces new financing for TempaSure cardiac ablation catheter for treatment of...
The financing, which was led by New Enterprise Associates and supported by existing investor, NBGI Ventures, will enable the company to continue to advance its next generation TempaSure ablation catheters and related clinical development programme.
New Heart Rhythm Society Choosing Wisely list details five commonly used treatments and procedures...
The Heart Rhythm Society developed the list as part of Choosing Wisely, an initiative of the American Board of Internal Medicine Foundation launched in 2012 aimed at curbing the use of certain tests and procedures that are not supported by clinical research.
Discrepancies found in antiarrhythmic drug prescriptions for atrial fibrillation
Chern-En Chiang, General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan, and colleagues, investigated the appropriate uses of antiarrhythmic drugs in atrial fibrillation patients and reported that there were inconsistencies in drug prescription compared to guidelines issued in 2006.
FDA conditionally approves new study design for the Artisan family of control catheters with...
The US Food and Drug Administration (FDA) has given conditional approval to Hansen Medical to change the company's study design of its ARTISAN-AF trial.
Early data for over-the-wire mesh ablation system is “encouraging”
At Europe AF (18-19 November, London, UK), Dirk Mueller, Bad Bevensen, Germany said that the initial results of the GENESIS study validated the usability of the Over-the-Wire Mesh Ablation System (OTW MAS, Encompass, Bard Electrophysiology) for paroxysmal atrial fibrillation.
Flec-SL trial proves efficacy of short-term antiarrhythmic drug treatment
Short-term antiarrhythmic drug treatment after cardioversion is nearly as effective in preventing recurrences of atrial fibrillation as long-term treatment, data from Flec-SL show.
New study to investigate the role of early radiofrequency ablation in delaying progression of...
ATTEST, a prospective, multicentre, randomised, controlled study will compare pulmonary vein isolation (using Biosense Webster's ThermoCool catheters and the company's Carto 3 or Carto XP mapping systems) with drug therapy (rate or rhythm control) in patients with paroxysmal atrial fibrillation.
Nerve surgery may help to suppress ventricular arrhythmias
Cardiologists from the University of California, Los Angeles (UCLA) have found that surgery to snip nerves related to the sympathetic nervous system on both the left and right sides of the chest, may be helpful in stopping electrical storms when other treatment methods have failed.
Cardiomyocyte product exhibits protective properties against arrhythmias and halts
Administering GRNCM1 (Gerom) by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.
Targeted drug therapy prevents exercise-induced arrhythmias
Researchers reported that flecainide can prevent potentially lethal arrhythmias in patients with a specific type of exercise or stress-induced arrhythmia disorder called CPVT.
AFNET-EAST trial enrols 1,000 patients
On 4 November the 1,000th patient was enrolled in the AFNET-EAST trial. The pan-European clinical trial compares two different treatment strategies in atrial fibrillation EAST trial compares early rhythm control therapy to usual care.
Two decades of development in AF treatment and education
This year marked the 20th edition of the Atrial Fibrillation Symposium (AFIB2022; 24–25 May, Copenhagen, Denmark) which, over its lifetime, has evolved to become...
Analysis sets out generalisability of EAST-AFNET 4 trial findings
Around 80% of patients diagnosed with atrial fibrillation (AF) in the UK population are eligible for early rhythm control, an analysis of the EAST-AFNET...
Expanded FDA approval for Medtronic’s Arctic Front cryoablation catheter
Medtronic has received US Food and Drug Administration (FDA) expanded approval for the Arctic Front family of cardiac cryoablation catheters for the treatment of...
Looking ahead to AFIB2021
Far from being the first event in the electrophysiology calendar now to make the switch to a digital-only format, the 2021 edition of the...
First patient enrolled in MOJAVE study of DSR 2.0
Sequana Medical NV has announced that the first patient has been enrolled in the MOJAVE study, a randomised controlled Phase 1/2a study in the...
MONITOR-HF trial results show improvement in quality of life scores for heart failure patients...
New data presented from an investigator-sponsored European trial found managing indicated heart failure patients with Abbott’s CardioMEMS HF system resulted in a significant improvement...
HRS 2023: Dynamic monitoring “improves access to care for AF patients”
Findings from a new clinical trial support use of implantable cardiac monitors (ICM) as a standard of care in managing patients with complex cardiac...
HRS 2023: SOLVE-CRT results “offer new hope for patients with hard-to-treat heart failure”
Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronisation therapy (CRT) among patients who were not able to be...
HRS 2023: Late-breaking clinical trial results support PFA as treatment option for atrial fibrillation
New data from three late-breaking clinical trials has demonstrated the safety and efficacy of pulsed field ablation (PFA) as a viable, non-thermal treatment option...
EHRA 2023: Novel score predicts heart failure following atrial fibrillation ablation
A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation (AF) ablation, according...
Experts update consensus on left atrial appendage closure
The Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Society (HRS) have released an updated expert consensus statement on transcatheter left...
Remote monitoring improves survival in heart failure patients analysis finds
Abbott has today announced new data that found monitoring patients remotely with haemodynamic pressure sensing technology, such as with its CardioMEMS HF System, can...
AF Symposium hears late-breaking data from RFA and PFA trials
Biosense Webster has announced an update and late-breaking data from trials across radiofrequency ablation (RFA) and pulsed field ablation (PFA) at the 2023 AF...
One-year data on CLAAS LAAO system demonstrate technical success of procedure
Conformal Medical has announced the presentation of one-year data from the company’s initial left atrial appendage occlusion (LAAO) cases with its novel CLAAS system...
New simulations show weak electrical pulses could treat atrial and ventricular fibrillations
With numerical simulations, researchers have demonstrated a new way to time weak electrical pulses that can stop certain life-threatening arrhythmias. Publishing their work in...
Catheter ablation shown to reduce mortality and hospitalisation in patients with atrial fibrillation and...
An analysis of randomised controlled trials (RCTs) has found catheter ablation reduces mortality and heart failure hospitalisations in patients with atrial fibrillation (AF) and...
RELIEF clinical study to assess use of Cardioform septal occluder for migraine relief
WL Gore & Associates has announced that it is initiating the RELIEF clinical study—an investigational study to evaluate the safety and efficacy of transcatheter...
Health economic analysis finds benefit to AF screening with Zio XT ambulatory patch
iRhythm Technologies has announced a new health economic analysis of the mSToPS study, presented at the American Heart Association (AHA) scientific sessions 2022 (5–7...
IMPACT II trial expands to USA following FDA exemption approval
The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to Attune Medical to evaluate the company’s ensoETM in the...
FDA approves clinical trial of SERF ablation for VT patients
Thermedical has announced that the US Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and...
CONFORM pivotal trial of CLAAS system begins enrolment
Conformal Medical has announced the launch of the CONFORM pivotal trial with the enrolment of the first patients at two US sites.
The investigational device...
HRS 2022: S-ICD can be considered as an alternative to transvenous devices in patients...
The use of a subcutaneous-implantable defibrillator (S-ICD, Boston Scientific) reduced the rate of major, lead-related complications by as much as 92% when compared to...
Trio of studies on Zio AF detection patch presented at ACC.22
iRhythm Technologies has announced the results of three clinical research studies presented at the American College of Cardiology’s annual scientific sessions (ACC 2022, 2–4...
Study provides “clear evidence” that alcohol is a risk factor for AF
Acute alcohol consumption is associated with a higher risk of atrial fibrillation (AF), a study published in Nature Cardiovascular Research has concluded
The study is...
SyMap Medical closes US$100 million financing round
SyMap Medical has announced the completion of a financing round which will be used to accelerate global clinical trials for the company’s renal mapping...
Pulsed field ablation poised to revolutionise the treatment of atrial fibrillation
The advent of pulsed field ablation (PFA) will revolutionise the treatment of atrial fibrillation (AF), Tom de Potter (Aalst, Belgium) tells Cardiac Rhythm News,...
Robotics in the EP lab: Pointing the way to the future
Benjamin D’Souza, assistant professor of Medicine at the University of Pennsylvania, cardiac electrophysiologist at Penn Presbyterian Medical Center, Philadelphia, USA, discusses the recent developments...
Use of the antibiotic-eluting envelope in CIEDs: Has it reached prime time?
Bhargav Vemulapalli, Shreya Srivastava and John Kassotis (New Brunswick, USA) review the potential use of antibiotic-eluting envelopes (ABEs) based on available clinical data, while...
ESC 2021: Drones touted as the future of defibrillator delivery
The world’s first feasibility study has found that drones can be used to deliver defibrillators to people with suspected cardiac arrest in the community....
AHA statement on AF and HFrEF positive for catheter ablation
The American Heart Association (AHA) has this week issued a scientific statement on the management of atrial fibrillation (AF) in patients with heart failure...
RAFT-AF fails to show benefit of AF ablation in heart failure patients
Among patients with both heart failure and atrial fibrillation (AF), treatment strategies focused on rhythm control, using catheter ablation, and those focused on rate...
Abiomed acquires breakthrough device company preCARDIA
Abiomed has acquired preCARDIA, developer of a proprietary catheter and controller to expand options for patients with acute decompensated heart failure (ADHF). The preCARDIA...
ACC.21: Registry data show low rate of stroke at one year following LAAO with...
Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston Scientific) device was associated with a low rate of stroke at one year, even...
Abbott initiates trial focusing on twin AF and heart failure treatments
Abbott has announced a new trial focused on improving the treatment for people simultaneously battling both atrial fibrillation (AF) and heart failure.
The TAP-CHF trial...
EHRA 2021: Efforts should be made to increase participation in atrial fibrillation screening
Further efforts should be made to increase participation in atrial fibrillation (AF) screening—particularly in elderly populations, where systematic screening for AF can help to...
Smartphone ECG screening app aided detection of AF among American Indians
A smartphone-based electrocardiogram (ECG) screening accurately detected previously unknown atrial fibrillation (AF) in American Indians, and more than half who were diagnosed were younger...
Putting the patient at the centre of the AF treatment strategy
This article was sponsored by Biosense Webster
Putting the patient at the centre of the discussion is vital to setting the right strategy for the...
Charity targets vaccine centres for opportunistic AF screening campaign
AF Association has launched an opportunistic screening programme to DETECT atrial fibrillation (AF) at COVID-19 vaccination clinics across the UK. The charity has created...
AF Symposium 2021: Studies explore lattice-tip catheter strategies for AF
Findings of two studies investigating the use of a lattice-tip catheter for the treatment of atrial fibrillation (AF) were presented during a late-breaking trial...
Remote technology in cardiac care is “here to stay”
Robert Klempfner, is director of the Israeli Center for Cardiovascular Research, and director of the Cardiovascular Prevention and the Cardiac Rehabilitation Institutes at Sheba...
CardioFocus announces 10,000-patient milestone for HeartLight ablation system
CardioFocus has announced that more than 10,000 patients worldwide have been treated with the HeartLight endoscopic ablation system.
The HeartLight system is a catheter ablation...
Anticoagulants fail to improve survival from COVID-19, Swedish study finds
The use of direct oral anticoagulants (DOACs) did not reduce the rate of hospitalisation, intensive care admission or fatality due to COVID-19, according to...
AHA 2020: Active AF screening associated with significant improvement in clinical outcomes at three...
Three-year clinical outcomes of the mHealth Screening to Prevent Strokes—mSToPS—study evaluating silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using Zio, the...
AHA 2020: Medtronic shares results of cryoablation studies
Medtronic has announced the presentation of results of three studies which it says demonstrate that cryoablation is superior to drug therapy for first-line treatment...
AHA 2020: InCarda announces presentation of INSTANT trial data
InCarda Therapeutics has announced the presentation of positive data from the open-label, dose-escalation Part A portion of the company’s multinational INSTANT Phase 2 clinical...
American Heart Association issues call for action on structural racism in cardiovascular care
Structural racism is a major cause of poor health and premature death from heart disease and stroke, according to a presidential advisory issued today...
European and Australian approvals granted for Abbott’s cardiac mapping system EnSite
Abbott has announced has announced the receipt of CE mark and approval in Australia for its EnSite X EP System, and is launching the...
Development of AF after CABG linked to higher risk of cerebrovascular accidents at 10...
Patients with postoperative atrial fibrillation (AF) after coronary artery bypass graft (CABG) surgery are at a higher risk of cerebrovascular accidents (CVAs) up to...
Catheter ablation linked to lower incidence of dementia in AF patients
People with atrial fibrillation (AF) have a reduced risk of dementia if they undergo catheter ablation to restore the normal rhythm of their heart,...
Twin studies demonstrate the evolving S-ICD evidence-base
This advertorial has been sponsored by Boston Scientific
Two landmark studies have been published in 2020 following the use of subcutaneous implantable cardioverter defibrillator (S-ICDs)...
Breakthrough status for Medtronic’s Tyrx for use with ventricular assist devices
Medtronic has received Breakthrough Device Designation status from the US Food and Drug Administration (FDA) for the Tyrx absorbable antibacterial driveline wrap, which is...
VitalConnect begins TELESTAR-TAVR remote monitoring study
VitalConnect has announced the commencement of the TELESTAR-TAVR clinical study—Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients)—monitoring patients undergoing...
ESC 2020 Congress: IMPACT-AFib finds no statistical difference in anticoagulant usage
A study investigating an educational intervention aimed at increasing the use of oral anticoagulants for stroke prevention among atrial fibrillation (AF) patients, found that...
Biosense Webster receives CE mark approval for QDot Micro ablation catheter
Johnson & Johnson Medical Devices has today announced European CE mark approval of Biosense Webster’s QDot Micro radiofrequency (RF) ablation catheter.
According to a press...
Integrated cardiac ablation performed using remote telerobotic system
Stereotaxis and Acutus Medical have announced the first integrated cardiac ablation procedure using remote TeleRobotic support. Gery Tomassoni of Baptist Health, Lexington, USA treated...
Prompt diagnosis “vital” in effective AF management
Dhiraj Gupta, consultant cardiologist and electrophysiologist at Liverpool Heart and Chest Hospital, (Liverpool, UK) discusses the current burden of atrial fibrillation (AF) on healthcare...
Holographic display may improve physician accuracy during cardiac ablation
Details of the first-in-human use of an augmented reality holographic display to aid physician accuracy during cardiac ablation have been published in the Journal...
Women taking beta blockers for hypertension may have higher risk of heart failure with...
Women taking beta blockers for hypertension with no prior history of cardiovascular disease have a nearly 5% higher risk for heart failure than men...
HRS 2020 Science: Packer assesses CABANA’s legacy
As part of this year’s HRS 2020 Science virtual event Douglas L Packer (Mayo Clinic, Rochester, USA) delivered the 2020 Eric N Prystowsky lecture...
Adagio Medical receives CE mark for iCLAS ablation system
Adagio Medical has received CE mark approval for its ultra-low temperature intelligent Continuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF)...
Virtual ACC: Largest left atrial appendage occlusion registry finds Watchman acute safety data “very...
Data from the National Cardiovascular Data Registry (NCDR) Left Atrial Appendage Occlusion (LAAO) Registry, which enrolled more than 38,000 patients implanted percutaneously with the...
CardioFocus submits HeartLight X3 PMA application to FDA
CardioFocus has submitted a pre-market approval (PMA) supplement to the US Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for...
Pedro Brugada
With his brothers Josep and Ramon, Pedro Brugada discovered the syndrome that bears their name. He reflects on his career highlights with Cardiac Rhythm...
AtriCure agrees to buy LARIAT developer SentreHEART
AtriCure has entered into a definitive agreement to acquire SentreHEART, which developed the LARIAT device for left atrial appendage closure in patients with atrial...
ESC 2019: Catheter ablation may be up to 10 times more effective than drug...
Results from the Atrial fibrillation progression trial (ATTEST) were presented on 31 August at the European Society of Cardiology (ESC) Congress 2019 in Paris,...
AtriCure enters into definitive agreement to acquire SentreHeart
AtriCure has revealed that it has entered into a definitive agreement to acquire SentreHeart. Under the terms of the acquisition agreement, the transaction consideration...
SENSE data show DX system is equivalent to dual-chamber ICDs and superior to single-chamber...
Biotronik has announced the publication of the SENSE trial results in the Journal of Cardiovascular Electrophysiology, proving Biotronik's DX system is equivalent to dual-chamber...
SentreHeart announces initial clinical use of the Lariat with EpiRail procedure for LAA exclusion
SentreHeart recently announced it has successfully completed nine first-in-human procedures utilising the Lariat with EpiRail at John Paul II hospital in Krakow, Poland. The...
New heart disease prevention guidelines focus on lifestyle changes and chronic disease management
The American College of Cardiology/American Heart Association (ACC/AHA) recently published new primary prevention of heart disease guidelines. The guidelines focus on traditional recommendations for...
Primary ICD therapy for patients with ischaemic cardiomyopathy in NYHA class I may have...
Primary implantable cardioverter-defibrillator (ICD) implantation may have an incremental benefit for patients who have ischaemic cardiomyopathy without heart failure symptoms. The findings, published in...
High power short duration ablation for atrial fibrillation: Safety and effectiveness
As part of a session on novel mapping and ablation technologies of atrial fibrillation (AF) at the recent AF Symposium in Boston, USA (24–26...
More research needed to justify continued use of wearable cardioverter defibrillator therapy for primary...
Ahmad Masri (Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA) and others report in JACC: Clinical Electrophysiology that a systematic...
Haran Burri
During his studies Haran Burri was fascinated by the simplicity of an ECG providing a vast amount of information on cardiac functions. This drew...
The link between atrial fibrillation and obstructive sleep apnoea
Obstructive sleep apnoea and atrial fibrillation (AF) have presented many challenges, including identifying which patients need to be assessed for obstructive sleep apnoea and...
First AI-driven wearable heart monitor that prevents heart disease and stroke to be released
Cambridge Heartwear is announcing the launch of their company and release of their Heartsense monitor in 2019. In the US, strokes are among the...
AHA 2018: Computerised-decision support has the potential to be a “powerful tool” for preventing...
Data presented at the 2018 American Heart Association (AHA) scientific session scientific sessions (10–12 November, Chicago, USA) indicate that the use of alert-based computerised-decision...
Tim Betts
For Tim Betts, a career in medicine was a natural choice. After graduating he knew he wanted to be a cardiologist and, with a...
AMBULATE study of VASCADE MVP system meets primary endpoint
The VASCADE MVP (Cardiva Medical), a vascular closure system designed specifically for multi-access venous closure following electrophysiology procedures such as arrhythmia ablation, met its...
Biotronik is now the exclusive US distributor of MoMe cardiac monitor
Biotronik is now the exclusive US distributor for InfoBionic's MoMe Kardia external cardiac diagnostic monitor, it has announced in a press release. The device...
The rise of smartphones and wearables for AF detection: WATCH-AF and DETECT-AF pro
How to best combine optimal screening and diagnosis for atrial fibrillation (AF) has long been a challenge. At European Heart Rhythm Association Congress (EHRA;...
Boston Scientific to buy cerebral protection system company
Boston Scientific has signed an agreement to acquire Claret Medical, which developed and commercialised the Sentinel cerebral embolic protection system. The device is used...
Continuous homebased ECG monitoring results in a significantly higher rate of AF diagnosis
The mHealth Screening To Prevent Strokes (mSToPS) randomised clinical trial showed that home-based wearable electrocardiogram (ECG) sensor patch monitoring, compared with delayed monitoring, resulted in...
Surgical treatment of atrial fibrillation results in higher complication rates when compared to catheter...
The total procedure-related complications after surgical minimally invasive pulmonary vein isolations (MIPI) were higher; this was mainly due to more major complications. During a...
Dhanunjaya Lakkireddy
Dhanunjaya Lakkireddy is executive medical director at The Kansas City Heart Rhythm Institute at HCA Midwest Health, Kansas, USA. He holds the title Professor...
Catheter ablation for atrial fibrillation: Lessons and developments
It was a year of big results for catheter ablation, continuing the procedure’s steady rise in atrial fibrillation (AF) management. Mark O’Neill, consultant cardiologist...
Successful ablation for ventricular tachycardia associated with markedly reduced mortality in advanced heart failure...
Wendy Tzou (University of Colorado School of Medicine, Denver, USA) and colleagues at the International Ventricular Tachycardia Ablation Center Collaborative group (IVTCC) published two...
Study finds the heart can terminate atrial fibrillation itself after local gene therapy
The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according...
Short-term DAPT is feasible for patients undergoing percutaneous LAA closure
Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and others report in EuroIntervention that a strategy of six weeks’ duration of dual antiplatelet therapy (DAPT)...
Noninvasive radioablation: Radiotherapy shows 99.9% VT burden reduction
A small study by Phillip S Cuculich (Washington University School of Medicine, St Louis, USA) et al has shown that radiation therapy, commonly used...
Evolocumab becomes first FDA-approved PCSK9 inhibitor for prevention of MI and stroke
Following a priority review by US Food and Drug Administration (FDA), evolocumab has received FDA approval in the USA. The drug is a PCSK9...
Congenital heart disease in children and young adults have 22 times higher risk of...
A study published in the Circulation journal has shown that the risk of atrial fibrillation (AF) in young adults and children who suffer from...
Men develop atrial fibrillation earlier than women; extra weight a factor
A study published in the American Heart Association’s journal Circulation has found that men develop atrial fibrillation (AF) about a decade earlier than women on...
Sabine Ernst
Sabine Ernst (lead electrophysiology research/consultant cardiologist, Royal Brompton and Harefield Hospital, London, UK and associate lead for Cardiac Imaging in the Biomedical Research Unit...
Cardiac resynchronisation therapy guided by imaging: The next step for optimal left ventricular lead...
Jonathan Behar (London, UK) co-inventor for the Guide CRT platform—shortlisted as a 2017 finalist for the EHRA Inventors Award—details the benefits of this novel...
EHRA Inventors Award ideas focus on cardiac remote monitoring and CRT optimisation
For the second-year running, the European Heart Rhythm Association (EHRA) held the EHRA Inventors Award competition at EHRA-EUROPACE CARDIOSTIM (18‒21 June, Vienna, Austria), a...
Princess Grace Hospital publishes data demonstrating more rapid transmural lesion formation utilising Stereotaxis Niobe...
Stereotaxis and Princess Grace Hospital in Monaco have announced the publication of a study comparing the speed of lesion formation of magnetic catheters using the Niobe system to manually...
Medtronic Reactive ATP therapy slows atrial fibrillation progression in real-world population
Medtronic has announced that its Reactive atrial-based antitachycardia pacing (ATP) therapy slows the progression of atrial fibrillation (AF) in patients with implanted cardiac devices....
Carlos Morillo
Carlos Morillo (Calgary, Canada) was one of the first physicians to document the potential of ablation of the pulmonary vein region as a strategy...
HRS 2017: Could etripamil nasal spray be a “game-changer” for paroxysmal supraventricular tachycardia?
A phase 2 trial (NODE-1) of a nasal spray formulation of etripamil (Milestone Pharmaceuticals) shows it is safe and effective at terminating paroxysmal supraventricular...
Flu, pneumonia vaccines may improve health of heart failure patients
Flu and pneumonia vaccines may improve the quality of life and outcomes of heart failure patients by providing cost-effective protection against life-threatening respiratory infections,...
Latest statistics show heart failure on the rise
The number of adults living with heart failure increased from about 5.7 million (2009-2012) to about 6.5 million (2011-2014), according to the American Heart...
Moderate, habitual alcohol intake associated with atrial fibrillation
People who binge drink often experience an irregular heartbeat or a heart “flutter,” sometimes referred to as “holiday heart syndrome.” However, people who drink...
Insights into current heart failure management
Piotr Ponikowski (Centre for Heart Disease, Clinical Military Hospital, Wroclaw, Poland), chairperson of the 2016 European Society of Cardiology (ESC) Guidelines for the diagnosis...
“We still have a long way to go to understand the benefits of remote...
In light of the recently presented results from REM-HF and MORE-CARE trials, Gerhard Hindricks and Nikolaos Dagres, both from Leipzig University Heart Center, Leipzig,...
OSYPKA AG launches HAT500® RF ablation system in Europe
OSYPKA AG has announced the launch of the HAT500® radiofrequency (RF) ablation system in Europe. The device received CE mark in October 2016.
OSYPKA AG,...
First-in-human data demonstrate safety and efficacy of new lead for temporary cardiac pacing
A first-in-human study has shown that a new temporary lead for cardiac pacing (Tempo Lead, BioTrace Medical) is safe and effective for use in...
Jeremy Ruskin
Jeremy Ruskin (Boston, USA), professor of medicine Harvard Medical School and director emeritus of the Cardiac Arrhythmia Service and Clinical Electrophysiology Laboratory at Mass...
Stereotaxis granted Chinese patent for Vdrive system with V-Loop manipulator
Stereotaxis has been awarded a patent protecting its Vdrive robotic navigation system with V-Loop variable loop catheter manipulator by the State Intellectual Property Office...
Big data analysis is “next frontier” in identifying harmful drug interactions
Coupling data mining of adverse event reports and electronic health records with targeted laboratory experiments, researchers have found a way to identify and confirm...
World Heart Federation launches global Roadmap to tackle atrial fibrillation
With the aim to help prevent atrial fibrillation (AF) and to improve its management worldwide— particularly in low- and middle-income countries—the World Heart Federation...
ESC 2016: Remote monitoring for heart failure may not improve clinical outcomes
Two randomised clinical trials presented at a Hot Line session of the European Society of Cardiology Congress (ESC; 27‒31 August, Rome, Italy) have shown...
EBR Systems receives FDA approval to begin IDE study of its wireless endocardial pacing...
EBR Systems has announced the US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) for its WiSE (Wireless Stimulation Endocardially) technology for cardiac...
Higher thyroid hormone levels linked to sudden cardiac death
Risk of death from a sudden loss of heart function has been found to be significantly greater in patients free thyroxine (FT4) levels at...
ESC 2016: Rethink of ICD implantation in non-ischaemic heart failure may be on the...
Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to medical treatment in patients with non-ischaemic systolic heart failure, according to results of...
ESC and EACTS launch first collaborative atrial fibrillation guidelines
The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) have been...
Boehringer Ingelheim launches RE-VECTO global programme to explore idarucizumab use in clinical practice
Boehringer Ingelheim has announced the launch of its global RE-VECTO programme for idarucizumab (Praxbind), the specific reversal agent for dabigatran etexilate (Pradaxa).
Idarucizumab is approved...
The OASIS trial: A critical appraisal
Recent results of the first randomised trial—OASIS trial—to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found poor outcomes...
Mediterranean diet without low-fat element reduces cardiovascular events
Hanna E Bloomfield (Minneapolis VA Medical Center, Minneapolis, USA) and others report in Annals of Internal Medicine that limited evidence, from randomised control trials, indicates...
Sudden cardiac death is the most common cause of death in atrial fibrillation patients,...
An analysis from the ENGAGE AF-TIMI 48 trial has found that sudden cardiac death was the single most common cause of death and accounted...
Relevance of imaging for ventricular tachycardia ablation
Cardiac imaging has emerged as an integral part of mapping and ablation in a variety of complex arrhythmias. Advances in imaging techniques, especially the...
Online medical information: A blessing or a curse?
The internet age has enabled patients to access a plethora of medical information. However, a potential drawback is that some of this information is...
Emerging ethical issues in genetic testing for sudden cardiac death
There is a lack of a uniform approach or guidelines when dealing with the ethical, legal and privacy concerns that can arise in cardiogenetics....
Catheter ablation is superior to amiodarone in the treatment of patients with heart failure...
New research indicates that catheter ablation may achieve greater long-term freedom from atrial fibrillation, as well as a reduction in unplanned hospitalisation and mortality...
New procedure uses heart rate to estimate life expectancy of infarct patients
The heart rate may be an indicator of a person’s life expectancy. A research team at the Technical University of Munich (TUM) (Munich, Germany)...
Importance of obstructive sleep apnoea in EP
Syed Rafay A Sabzwari and Dhanunjaya Lakkireddy (Kansas City, USA) review the importance of obstructive sleep apnoea (OSA) in electrophysiology and cardiology at large,...
Radiofrequency catheter ablation shows benefits for recurrent ventricular tachycardia patients
A prospective, multicentre study—THERMOCOOL VT—analysing a cohort of non-randomised patients, published in February in the Journal of the American College of Cardiology, has shown...
Yoga may help as a complementary treatment for paroxysmal atrial fibrillation
A randomised controlled study has found that yoga with light movements and deep breathing may lead to improved quality of life, as well as...
Ventricular tachycardia ablation in Chagas disease
Guilherme Fenelon (Sao Paulo, Brazil) overviews the role of ablation of ventricular tachycardia in Chagas disease. He says: catheter ablation in Chagas disease remains...
Rethink of ICD implantation in non-ischaemic heart failure may be on the cards
Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to medical treatment in patients with non-ischaemic systolic heart failure, according to results of...
First randomised trial shows “poor outcomes” with rotor ablation
OASIS, the first randomised, controlled, multicentre clinical trial to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found “poor...
Medtronic’s Reveal LINQ detects atrial fibrillation at higher rate than previously recorded
Medtronic has announced one-year results from a real-world study of patients who had a cryptogenic stroke, or stroke of unknown cause.
HeartLight System gets FDA approval for atrial fibrillation treatment
CardioFocus has announced that it has received premarket approval from the US Food and Drug Administration (FDA) for its HeartLight Endoscopic Ablation System for the treatment of patients with paroxysmal atrial fibrillation.
Fluoroscopy times and radiation dose reduced in atrial fibrillation ablation with contact force-sensing technology
A real-world study has found that the SmartTouch (Biosense Webster) contact force-sensing catheter coupled with an Advanced Catheter Location feature during atrial fibrillation (AF) ablation reduced fluoroscopy times by 77%, radiation dose by 71% and procedural time by 19%.
How innovation can unleash tremendous growth in the $3.4 billion AF ablation market
Shlomo Ben-Haim (London, UK), a professor of medicine and serial entrepreneur in the medical device industry, examines the drivers of expansion of the atrial...
Hybrid and surgical atrial fibrillation ablation: Opportunity, threat or both?
Despite major advances in techniques and technology over the past 15 years, the clinical outcomes for catheter ablation in non-paroxysmal atrial fibrillation patients remain...
Has leadless pacing changed practice?
Chu-Pak Lau explores the development and use of externally-powered and entirely intracardiac leadless pacemakers, and considers the effect they have had on clinical practice.
New study evaluating whether pacemakers with closed loop stimulation prevent reflex syncope begins
BIOSync CLS will investigate the efficacy of the uniquely physiologic rate response sensor CLS in preventing syncope.
Debate on defibrillation testing continues
Speaking at a debate about the value of defibrillator threshold testing in patients with ICDs, Klaus Witte (Leeds, UK) told delegates at the Heart Rhythm Congress that such testing was a "pointless" intervention because it does not provide benefit and may be associated with adverse events. Nick Linker (Middlesbrough, UK), who argued against Witte, said that there is still a significant proportion of patients-who were not included in the major trials of defibrillation testing-for whom
Second survey on cardiac resynchronisation therapy utilisation in Europe launched
The European Heart Rhythm Society (EHRA) and Heart Failure Association (HFA) have initiated the European Cardiac Resynchronization Therapy Survey II, an initiative designed to...
Michael Glikson
Michael Glikson (Tel Hashomer, Israel) has contributed to the development of technologies for CRT, modern lead extraction, advanced mapping ablation of AF and VT and LAA occlusion. Glikson's current projects as president of the Israel Heart Society and co-president of the International Dead Sea Symposium (IDSS) on Innovations in Cardiac Arrhythmias and Device Therapy reflect his innovative approach in the field. He speaks to Cardiac Rhythm News about these projects, other highlights in his
CardioFocus’ HeartLight PMA for the treatment of atrial fibrillation filed and accepted for review...
The accepted PMA application includes safety and effectiveness data from the company's multicentre HeartLight pivotal clinical trial, a randomised, controlled study in which a total of 353 patients were treated at 19 US centres.
Biotronik enrols first patients in the BIO|GUARD-MI study
Study evaluates whether early detection of cardiac arrhythmias by BioMonitor with home monitoring reduces major cardiovascular events in post-acute myocardial infarction patients.
Hansen Medical announces enrolment of initial cohort in ARTISAN US clinical trial
The trial will evaluate the safety and effectiveness of the Sensei robotic system and Artisan family of catheters for introducing and positioning radiofrequency ablation catheters in patients with symptomatic, drug-refractory paroxysmal atrial fibrillation.
Fibrin and stem cell patches show promise for heart healing
findings of a study demonstrate the promise in regenerating cardiac tissue using engineered patches made up of a mixture of fibrin and mesenchymal stem cells (MSCs) derived from human umbilical cord blood.
Michael Gold
William Gold spoke to Cardiac Rhythm News about his involvement in various clinical trials, his views on the upcoming treatment options for heart failure and the highlights of this year's HRS meeting.
New data show safety and efficacy of specifically designed implantable cardioverter defibrillators for MRI...
Early performance results of the first-in-human international study of Medtronic's Micra Transcatheter Pacing System (TPS) have demonstrated the device is safe and effective.
HeartLight US pivotal study meets primary efficacy and safety endpoints
The trial, which randomised CardioFocus' HeartLight one-to-one versus the Biosense Webster Thermocool catheter, met both primary efficacy and safety endpoints and demonstrated a low learning curve for physicians.
Long-term sustained weight loss associated with significant reduction in AF burden
The first study investigating the long-term effects of weight loss and the degree of weight fluctuation on atrial fibrillation (AF) burden has found that obese patients with this arrhythmia who lost at least 10% of their body weight were six times more likely to achieve long-term freedom from atrial fibrillation.
Get With The Guidelines-AFIB: A US quality improvement programme for atrial fibrillation patients
Guideline adherence to anticoagulation in atrial fibrillation seems to be more difficult compared to other quality measures in cardiology practice. William Lewis (chair of...
Milestone Pharmaceuticals receives FDA clearance of MSP-2017 phase 2 IND
The trial design cleared by FDA is a multiple arm phase 2, multicentre, placebo-controlled study of intranasal administration of MSP-2017 for the conversion of PSVT to sinus rhythm.
Non-invasive identification of drivers in persistent AF
In paroxysmal atrial fibrillation, pulmonary vein isolation is successful while the results in persistent atrial fibrillation are less satisfactory because of ill-defined atrial substrate...
St. Jude Medical begins study of ablation procedures to treat ventricular tachycardia
The FlexAbility ablation catheter will be used to assess benefits of catheter ablation as an adjunctive therapy for patients at risk for life-threatening arrhythmias.
New data analysis from CHAMPION shows significant reductions in heart failure hospitalisations with CardioMEMS
St Jude Medical has announced a new data analysis from the CHAMPION clinical trial-in a subgroup of patients with renal failure-that showed reduced heart failure hospitalisation by 42% for patients managed with pulmonary artery pressure based technology compared to a control group.
SMART-AF trial shows AF ablation with contact force sensing catheter is safe and effective
Results from the SMART-AF trial, recently published in the Journal of the American College of Cardiology, have shown that the ThermoCool SmartTouch contact force-sensing catheter is safe and effective for the treatment of drug-refractory symptomatic paroxysmal atrial fibrillation.
Joint consensus on antithrombotic use in AF patients with acute coronary syndrome published
A new European joint consensus document on the use of antithrombotic drugs in patients with atrial fibrillation presenting with an acute coronary syndrome and undergoing percutaneous coronary intervention has been published in the European Heart Journal.
IN-TIME trial results on remote monitoring published in The Lancet
Biotronik has announced that the IN-TIME study results have been published in The Lancet. The randomised, controlled trial is the first worldwide to demonstrate that automatic, implant-based remote monitoring leads to significant clinical benefits for heart failure patients.
The incidence of sudden death in heart transplant patients has not improved over the...
A first, large multicentre study in the United States has found that despite the advances in clinical management strategies after heart transplantation, there has not been an improvement in the incidence of sudden cardiac death (SCD) in heart transplant patients over the last three decades.
Physicians implant world’s first ProMRI Quadripolar CRT-D system to treat heart failure
With Sentus quadripolar leads and the Inventra series, Biotronik offers the only devices for patients with heart failure worldwide that are approved for MRI use.
What is the best strategy for managing atrial fibrillation?
John D Day, president-elect of the Heart Rhythm Society writes that many cases of atrial fibrillation in the USA could be prevented or reversed with lifestyles focussed on health.
Novel oral anticoagulants an option for patients with atrial fibrillation
Offering patients anticoagulants could help prevent thousands of strokes and premature deaths from atrial fibrillation (AF), according to NICE.
EPIC Alliance questions sports ban for young ICD patients
In her presentation at the German Cardiac Society's annual conference, Karin Nentwich (Bad Neustadt, Germany) concluded that implantable defibrillators are not contraindicated for young people engaging in physical education, sports and-within limits-competitive sports.
IN-TIME shows equal benefit of home telemonitoring in ICD and CRT-D patients
Home telemonitoring is equally effective in ICD and CRT-D patients, a subanalysis of the IN-TIME trial has shown.
Aggressive lifestyle management helps improve success rate after AF ablation
Researchers in Australia have found that aggressive management of cardiovascular risk factors and weight can dramatically impact the long-term success rate of freedom from atrial fibrillation following ablation.
Outbursts of anger linked to greater risk of heart attacks and strokes
Outbursts of anger may trigger heart attacks, strokes and other cardiovascular problems in the two hours immediately afterwards, according to the first study to systematically evaluate previous research into the link between the extreme emotion and all cardiovascular outcomes.
New atrial fibrillation classification by ECG will help GPs deliver personalised treatment
A new classification of atrial fibrillation (AF) by electrocardiogram (ECG) is set to be developed by European experts to aid personalised management of condition.
Resynchronisation in narrow QRS patients questioned
The results of the EchoCRT study show that cardiac resynchronisation therapy (CRT) does not reduce the rate of death or hospitalisation and may increase mortality in heart failure patients with a QRS duration of less than 130msec
2010 ESC guidelines on atrial fibrillation followed by seven European countries, PREFER in AF...
The guideline-recommended use of oral anticoagulation has increased compared to previous registries, as well as the use of antiarrhythmic drugs and catheter ablation procedures. Data have recently been published in Europace
IN-TIME study shows significant reduction in all-cause mortality in ICD and CRT-D patients with...
Results from the IN-TIME study have shown a significant reduction in all-cause mortality in heart failure patients with implantable cardioverter defibrillators (ICDs) or cardiac resynchonisation therapy defibrillators (CRT-Ds) fitted with remote monitoring compared to standard care therapy.
Effectiveness of left atrial appendage exclusion, ligation and occlusion in reducing stroke risk in...
Andre d'Avila and Arash Aryana write on three different left atrial appendage strategies aimed to reduce stroke risk in atrial fibrillation patients. d'Avila presented this analysis at Heart Rhythm (Denver, USA, 8-5 May 2013).
Latest National ICD Registry captures data of about “90% of all ICDs implanted in...
Cardiac Rhythm News speaks to Mark S Kremers, chairman, ICD Registry Steering Committee, on the results from the latest US ICD registry led by the Heart Rhythm Society and the American College of Cardiology Foundation. In this registry, Kremers said: "about 90% of all ICDs implanted in the USA are tracked".
Zio Patch shows improved paroxysmal atrial fibrillation detection compared with 24-hour Holter Monitor
Zio Patch, anambulatory cardiac monitoring system (iRhythm), has shown benefit of long-term monitoring or paroxysmal atrial fibrillation patients and significant impact on treatment strategy.
Long-term results of PROTECT AF confirm left atrial appendage closure is non-inferior to warfarin
Vivek Y Reddy, Mount Sinai School of Medicine, New York, USA, and others recently reported the updated results ahead of print in Circulation.
Biotronik Home Monitoring is efficient and effective, MoniC study shows
The MoniC study, conducted at the Campus Charite Mitte, Berlin, addressed the feasibility, safety, workload and clinical usefulness of a centralised Biotronik Home Monitoring model.
Gregory YH Lip
Gregory YH Lip, Birmingham, UK, talked to Cardiac Rhythm News about the highlights of his career, including his mother as his biggest influence, and the recent update to the European Society of Cardiology (ESC) guidelines for the management of atrial fibrillation.
Are patients with atrial fibrillation at increased risk of developing dementia?
Pasquale Santangeli, Texas Cardiac Arrhythmia Institute, St David's Medical Centre, Austin, USA, spoke to Cardiac Rhythm News about the link between atrial fibrillation and dementia.
Biotronik Home Monitoring reduces inappropriate ICD shocks by 52%
ECOST trial results published in European Heart Journal show the safety and efficacy of Home Monitoring.
Do syncope units work?
Syncope is a very common medical problem with a yearly incidence of around 10 patients per 1,000 inhabitants. However, the rate of diagnosis when using a non-standardised approach is 42-54%. Mohamed Hamdan reviews the evidence for syncope units and whether they can be used to improve the rate of diagnosis of syncope.
New consensus statement on CRT unveiled at Cardiostim
Cardiac Rhythm News talked to Jean-Claude Daubert, who is one of the founders of the European Heart Rhythm Association (EHRA), about key details of the new consensus statement on cardiac resynchronisation therapy (CRT) device implantation and follow-up.
European perspective on the RCPE guidelines
John Camm and Karl-Heinz Kuck, on behalf of the European Heart Rhythm Association (EHRA), review the recent consensus document from the Royal College of Physicians of Edinburgh (RCPE) on the management of atrial fibrillation.
Radiofrequency catheter ablation is safe and effective in the octogenarian patient with atrial fibrillation
A study published in the Journal of Cardiovascular Electrophysiology shows that catheter ablation of octogenarians with atrial fibrillation is as safe and effective as catheter ablation of atrial fibrillation in younger patients
Invasive strategy improves survival in patients with myotonic dystrophy and conduction system disease
A study published in the Journal of the American Medical Association has found that an invasive strategy of systematic electrophysiology study and prophylactic pacemaker implantation in patients with myotonic dystrophy type one and major infranodal conduction delays was associated with a higher rate of nine-year survival than a non-invasive strategy.
Angelo Auricchio
Angelo Auricchio, president of the European Heart Rhythm Association, reviews the highlights of his impressive career with Cardiac Rhythm News.
The future of remote monitoring
Stefan Sack, Munich, Germany speaks to Cardiac Rhythm News about what current data for remote monitoring shows and what studies on remote monitoring are currently investigating.
Hansen Medical initiates clinical trial evaluating Sensei X robotic system for ventricular tachycardia
The Early robotic ablation by substrate elimination of ventricular tachycardia study (ERASE-VT), is planned to enrol 200 patients with implantable cardioverter defibrillators (ICDs) at up to eight sites in Europe.
Andrea Natale
Andrea Natale, co-president of Venice Arrhythmias (9-12 October 2011), is one of the pioneers in ablation of atrial fibrillation, he spoke to Cardiac Rhythm News about this as one of his proudest moments, he also told who inspired him into electrophysiology and what is expected for Venice Arrythmias 2011.
Remote magnetic navigation and ablation shows promise in patients with scar-related ventricular tachycardia
"The main advantage of the Niobe Remote Magnetic Navigation System (Stereotaxis), is the precise mapping and identification of the critical diseased portions of the heart that allows physicians to perform ablation in a more effective way," said Petr Neuzil, lead investigator of the STOP-VT study presented at the ESC Congress in Paris.
ECOST trial demonstrates reduction of inappropriate shocks and improvement of battery longevity for ICD...
ECOST is the first trial to show a 52% reduction of the number of patients with inappropriate shocks and a 72% reduction in the risk of hospitalisations related to inappropriate shocks.
Landmark pan-European atrial fibrillation trial recruits first patient
The EAST clinical trial is the largest pan-European study to evaluate whether an early and comprehensive rhythm control treatment of patients with early onset atrial fibrillation produces better patient outcomes than usual care alone.
Remote monitoring – the remote future of ICD?
The popularity of remote monitoring systems for implantable cardiac rhythm management devices is slowly increasing, according to Vidal Essebag, McGill University, Montreal, Canada.
Atrial fibrillation is emerging as the new epidemic
Despite recent advances in the treatment of heart rhythm disturbances, mortality and morbidity rates associated with AF remain unacceptably high, according to a joint report by the German Competence Network on Atrial Fibrillation (AFNET) and the European Heart Rhythm Association (EHRA).
Cameron to spend US$107 million on FDA trial and manufacture of implantable cardiac defibrillator
The S-ICD system (Cameron) is the only implantable defibrillator that does not require electrical wires in the heart. This system is implanted using a completely subcutaneous procedure that leaves the heart and blood vessels untouched and intact.
New stretchable device promises to make ablation simpler
The new tool has all necessary medical devices printed on a standard balloon catheter: a device for eliminating damaged tissue using heat, temperature and pressure sensors, a light-emitting diode (LED) and an electrocardiogram sensor.
Peter Schwartz
Peter Schwartz tells Cardiac Rhythm News about loving his research, being best man at a patient's wedding and having an article about golf published in a medical journal.
Biotronik announces start of the NORDIC ICD clinical trial
This trial investigates whether implantable cardioverter defibrillator (ICD) implantation without an intraoperative defibrillation test is noninferior to ICD implantation with intraoperative defibrillation testing.
NICE guidance gives people living with AF more treatment options
Technology appraisal recommends the use of dronedarone in treating Atrial Fibrillation under specific conditions.
More strategy, fewer shocks
Lessons in programming to be learnt from findings, claims Bruce Wilkoff.
Bruce L Wilkoff
Bruce L Wilkoff, The Cleveland Clinic, Cleveland, USA, has been involved in the development of several cardiac devices. He tells Cardiac Rhythm News which of them he considers the most important.
Copy of FDA approves dronedarone for patients with atrial fibrillation or atrial flutter
Approved to reduce the risk of cardiovascular hospitalization, Multaq will be launched this summer in the US by Sanofi-aventis.
Europace 2009 calls for more remote monitoring of implantable devices
More European countries need to embrace the remote monitoring of cardiac implantable devices, rather than offering face to face clinic visits, concluded a press briefing at Europace 2009.
Mayo Clinic receives US$48 million in grants to study catheter ablation for AF
The CABANA trial is designed to determine whether catheter ablation is more effective than drug therapy for the treatment of atrial fibrillation.
Mild heart failure: The REVERSE results
Dirk J van Veldhuisen analyses the findings on the use of CRT for heart failure patients classes I and II and how the results will impact in future studies.
Stanley Nattel
Stanley Nattel, Montreal, Canada, spoke to Cardiac Rhythm News about his career, the challenges facing electrophysiology, and the future of the research on drugs for arrhythmias.
